Living with or without cyclins and cyclin-dependent kinases
Open accessThe DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Abstract
Entry into, progression through, and exit from the G1 phase of the mammalian cell cycle in response to extracellular mitogenic cues are presumed to be governed by cyclin-dependent kinases (Cdks) regulated by the D-type and E-type cyclins. Studies performed over more than a decade have supported the view that these holoenzymes are important, if not required, for these processes. However, recent experiments in which the genes encoding all three D-type cyclins, the two E-type cyclins, cyclin D-dependent Cdk4 and Cdk6, or cyclin E-dependent Cdk2 have been disrupted in the mouse germ line have revealed that much of fetal development occurs normally in their absence. Thus, none of these genes is strictly essential for cell cycle progression. To what extent is the prevailing dogma incorrect, and how can the recent findings be reconciled with past work?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Despite the high frequency of mutations epistatically targeting the RB signaling pathway in cancer cells, inactivation of the individual cyclin D, Cdk4/6, and Ink4a genes in mice, while leading to specific developmental defects when disrupted alone or in combination, established that their functions were nonessential for the cell cycle per se (62-64).”
From Targeting CDK4 and CDK6: From Discovery to Therapy (2016) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“it may well prove that mutations affecting other cell cycle regulators, such as amplification of cyclin E, loss of p27Kip1 or p21Cip1 and activation of CDK2 would bypass the requirement of tumor cells for CDK4/6 activity, thereby also conferring de novo resistance (62-64).”
From Targeting CDK4 and CDK6: From Discovery to Therapy (2016) · cites this paper as [63]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370 · cited 1×
“…the idea that mutant " cancer stem cells, " rather than their differentiated progeny that may make up the bulk of a tumor, are the only cells strictly responsible for durable tumor maintenance and, in turn, for resistance to therapy (Reya et al. 2001; Taipale and Beachy 2001; Al-Hajj et al. 2003).”
BackgroundStem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738 · cited 2×
“The cells that give rise to many cancers have both the self-renewal and differentiating capacities of tissue stem cells, raising the idea that mutant “cancer stem cells,” rather than their differentiated progeny that may make up the bulk of a tumor, are the only cells strictly responsible for durable tumor maintenance…”
BackgroundCDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115 · cited 1×
“The AKT kinase controls the subcellular localization of Cip/Kip proteins as well (Liang et al. 2002; Shin et al. 2002; Viglietto et al. 2002), providing yet another avenue for cyclin E–Cdk2 regulation in response to extracellular cues.”
BackgroundSelf-citationA new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650 · cited 2×
“1994); conversely, attenuation of Cdk4 activity by polypeptide inhibitors of the INK4 gene family (Serrano et al. 1993) or by Cdk4-selective drugs (Tetsu and McCormick 2003) results in G1-phase arrest and cell cycle exit.”
BackgroundInhibitors of mammalian G1 cyclin-dependent kinases.
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,243 · cited 6×
“1993), and by induction of polypeptide inhibitors of the Cip/Kip family in many physiologic settings (Sherr and Roberts 1995) result in G1-phase arrest.”
BackgroundInfluentialSelf-citationG1 phase progression: Cycling on cue
Sherr, C. J. (1994) · Cell · doi:10.1016/0092-8674(94)90540-1 · Cited by 2,674 · cited 1×
“If this occurs before the G1/S boundary, cells exit the cycle without replicating their DNA, but if it occurs afterward, cells complete mitosis and exit from the cycle in the next G1 interval (Matsushime et al. 1994; Sherr 1994).”
BackgroundSelf-citationCYCLIN-DEPENDENT KINASES: Engines, Clocks, and Microprocessors
Morgan, D. O. (1997) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.13.1.261 · Cited by 2,259 · cited 3×
“The relevant proteins include three D-type cyclins (D1, D2, and D3) that, in different combinations, bind to, and allosterically regulate, one of two Cdk subunits, Cdk4 and Cdk6, as well as the E-type cyclins (E1 and E2), which, in analogous fashion, govern the activity of a single catalytic subunit, Cdk2 (Morgan 1997…”
BackgroundInfluentialGlycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
Diehl, J. A., Cheng, M., Roussel, M. F., & Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.22.3499 · Cited by 2,130 · cited 2×
“…GSK-3, an enzyme that is inhibited by the phosphatidylinositol 3-kinase/AKT signaling pathway , in determining the stability of cyclin E implies that its life history, like that of cyclin D1 (Diehl et al. 1998), can be directly influenced by at least one mitogen-dependent kinase signaling cascade.”
BackgroundSelf-citationPolyak, K., Kato, J. Y., Solomon, M. J., Sherr, C. J., Massague, J., Roberts, J. M., & Koff, A. (1994) · Genes & Development · doi:10.1101/gad.8.1.9 · Cited by 1,954 · cited 1×
“, two potent inhibitors of Cdk2 (Polyak et al. 1994; Reynisdottir et al. 1995; Sherr and Roberts 1995).”
Self-citationCyclin D1 is a nuclear protein required for cell cycle progression in G1
Baldin, V, Lukas, J., Marcote, M. J., Pagano, M., & Draetta, G. (1993) · Genes & Development · doi:10.1101/gad.7.5.812 · Cited by 1,614 · cited 2×
“In continuously dividing cells, cyclin D1 exits the cell nucleus during S phase, and its turnover is accelerated throughout this interval (Baldin et al. 1993; Diehl et al. 1998), but Rasdependent cyclin D1 synthesis and its stabilization in G2 phase allow it to reaccumulate before cells divide (Guo…”
BackgroundNew functional activities for the p21 family of CDK inhibitors.
LaBaer, J., Garrett, M. D., Stevenson, L. F., Slingerland, J. M., Sandhu, C., Chou, H. S., Fattaey, A., & Harlow, E. (1997) · Genes & Development · doi:10.1101/gad.11.7.847 · Cited by 1,402 · cited 1×
“Binding of Cip/Kip proteins to cyclin D1–Cdk4 stabilizes the complex and facilitates its nuclear import, without necessarily inhibiting cyclin Dassociated kinase activity (LaBaer et al. 1997; Cheng et al. 1999).”
BackgroundThe Hedgehog and Wnt signalling pathways in cancer
Taipale, J., & Beachy, P. A. (2001) · Nature · doi:10.1038/35077219 · Cited by 1,393 · cited 2×
“The cells that give rise to many cancers have both the self-renewal and differentiating capacities of tissue stem cells, raising the idea that mutant “cancer stem cells,” rather than their differentiated progeny that may make up the bulk of a tumor, are the only cells strictly responsible for durable tumor maintenance…”
BackgroundColony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle
Matsushime, H., Roussel, M. F., Ashmun, R. A., & Sherr, C. J. (1991) · Cell · doi:10.1016/0092-8674(91)90101-4 · Cited by 1,167 · cited 3×
“Although it was already known that cyclin D1 was expressed in some cell types but not others (Matsushime et al. 1991), mice lacking cyclin D1 were viable and exhibited only focal developmental anomalies confined largely to the retina and to developing breast tissue during pregnancy (Table 1).”
BackgroundInfluentialSelf-citationSibling rivalry in the E2F family
Trimarchi, J. M., & Lees, J. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm714 · Cited by 1,158 · cited 2×
“This process controls an E2F-dependent transcriptional program that activates a battery of genes whose products are required for DNA metabolism and replication (Trimarchi and Lees 2002).”
BackgroundThe Rb/E2F pathway: expanding roles and emerging paradigms
Harbour, J. W., & Dean, D. C. (2000) · Genes & Development · doi:10.1101/gad.813200 · Cited by 1,153 · cited 1×
“Cyclin E–Cdk2 also preferentially phosphorylates Rb on different sites from the cyclin D-dependent kinases, and these modifications may differentially impact on the interactions of Rb with E2Fs, histone deacetylases, and other chromatin-remodeling proteins (Harbour and Dean 2000).”
BackgroundHuman Cyclin E, a Nuclear Protein Essential for the G1-to-S Phase Transition
Ohtsubo, M., Theodoras, A. M., Schumacher, J., Roberts, J. M., & Pagano, M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2612 · Cited by 1,148 · cited 2×
“In turn, microinjection of antibodies against cyclin E into cultured mammalian cells prevents the transition from quiescence (G0) into S phase (Ohtsubo et al. 1995), and inactivation of the cyclin E gene in Drosophila blocks all mitotic cell cycles and endocycles (Knoblich et al. 1994).”
BackgroundSelf-citationCheng, M., Olivier, P., Diehl, J. A., Fero, M., Roussel, M. F., Roberts, J. M., & Sherr, C. J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.6.1571 · Cited by 1,142 · cited 3×
“Cip1 did not stably express D-type cyclins and had >90% reduction in net cyclin D-dependent kinase activity, but nevertheless proliferated normally (Cheng et al. 1999).”
BackgroundSelf-citationDistinct Roles for Cyclin-Dependent Kinases in Cell Cycle Control
van den Heuvel, S., & Harlow, E. (1993) · Science · doi:10.1126/science.8266103 · Cited by 1,092 · cited 1×
“Likewise, inhibition of Cdk2 activity by dominant-negative, catalytically inactive versions of the kinase (van den Heuvel and Harlow 1993), by microinjected antibodies to Cdk2 (Pagano et al. 1993; Tsai et al. 1993), and by induction of polypeptide inhibitors of the Cip/Kip family in many…”
BackgroundD-type cyclin-dependent kinase activity in mammalian cells.
Matsushime, H., Quelle, D. E., Shurtleff, S. A., Shibuya, M., Sherr, C. J., & Kato, J. Y. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.2066 · Cited by 1,064 · cited 1×
“If this occurs before the G1/S boundary, cells exit the cycle without replicating their DNA, but if it occurs afterward, cells complete mitosis and exit from the cycle in the next G1 interval (Matsushime et al. 1994; Sherr 1994).”
BackgroundSelf-citationMurray, A. W. (2004) · Cell · doi:10.1016/s0092-8674(03)01080-8 · Cited by 1,053 · cited 3×
“The current thinking is that the major differences between cyclins reflect their timing of expression, their subcellular localization, and other biochemical differences that help to mediate Cdk substrate access and selection, thereby allowing a more refined tuning of the cell cycle oscillator (Roberts 1999; Murray 200…”
Formation and Activation of a Cyclin E-cdk2 Complex During the G 1 Phase of the Human Cell Cycle
Koff, A., Giordano, A., Desai, D., Yamashita, K., Harper, J. W., Elledge, S., Nishimoto, T., Morgan, D. O., Franza, B. R., & Roberts, J. M. (1992) · Science · doi:10.1126/science.1388288 · Cited by 1,043 · cited 2×
“Unlike the cyclin D-dependent kinases, the activity of cyclin E–Cdk2 is periodic and maximal at the G1- to S-phase transition (Dulic et al. 1992; Koff et al. 1992).”
BackgroundSelf-citationOverexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts.
Quelle, D. E., Ashmun, R. A., Shurtleff, S. A., Kato, J. Y., Bar-Sagi, D., Roussel, M. F., & Sherr, C. J. (1993) · Genes & Development · doi:10.1101/gad.7.8.1559 · Cited by 1,032 · cited 4×
“Microinjected antibodies or antisense constructs directed to D-type cyclins can interfere with G1- phase progression, but are without effect during other cell cycle intervals (Baldin et al. 1993; Quelle et al. 1993; Lukas et al. 1994).”
BackgroundInfluentialSelf-citationCyclin D1 provides a link between development and oncogenesis in the retina and breast
Sicinski, P., Donaher, J. L., Parker, S. B., Li, T., Fazeli, A., Gardner, H., Haslam, S. Z., Bronson, R. T., Elledge, S. J., & Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90034-9 · Cited by 1,021
Functional interactions of the retinoblastoma protein with mammalian D-type cyclins
Ewen, M. E., Sluss, H. K., Sherr, C. J., Matsushime, H., Kato, J.-Y., & Livingston, D. M. (1993) · Cell · doi:10.1016/0092-8674(93)90136-e · Cited by 1,010 · cited 1×
“These cells continued to synthesize D-type cyclins, which, based on earlier studies, can directly bind to and activate Cdk2 in vitro (Matsushime et al. 1992; Ewen et al. 1993).”
BackgroundSelf-citationResnitzky, D., Gossen, M., Bujard, H., & Reed, S. I. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1669-1679.1994 · Cited by 965
Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.
Reynisdóttir, I., Polyak, K., Iavarone, A., & Massagué, J. (1995) · Genes & Development · doi:10.1101/gad.9.15.1831 · Cited by 962 · cited 2×
“, two potent inhibitors of Cdk2 (Polyak et al. 1994; Reynisdottir et al. 1995; Sherr and Roberts 1995).”
BackgroundPKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest
Liang, J., Zubovitz, J., Petrocelli, T., Kotchetkov, R., Connor, M. K., Han, K., Lee, J.-H., Ciarallo, S., Catzavelos, C., Beniston, R., et al. (2002) · Nature Medicine · doi:10.1038/nm761 · Cited by 948 · cited 1×
“The AKT kinase controls the subcellular localization of Cip/Kip proteins as well (Liang et al. 2002; Shin et al. 2002; Viglietto et al. 2002), providing yet another avenue for cyclin E–Cdk2 regulation in response to extracellular cues.”
BackgroundSpecific protection against breast cancers by cyclin D1 ablation
Yu, Q., Geng, Y., & Sicinski, P. (2001) · Nature · doi:10.1038/35082500 · Cited by 934 · cited 3×
“Similarly, cyclin D1 inactivation confers resistance to breast cancers induced by oncogenic Neu or Ras transgenes targeted to the mammary gland (Yu et al. 2001) and to intestinal tumors resulting from Apc loss and constitutive -catenin signaling (Hulit et al.”
BackgroundCyclin E-CDK2 is a regulator of p27Kip1.
Sheaff, R. J., Groudine, M., Gordon, M., Roberts, J. M., & Clurman, B. E. (1997) · Genes & Development · doi:10.1101/gad.11.11.1464 · Cited by 911 · cited 1×
“Cyclin E–Cdk2 does not sequester p27 Kip1 , but rather phosphorylates it on a single threonine residue (Thr 187) (Sheaff et al. 1997; Vlach Disabling cyclins and Cdks et al. 1997), providing a recognition motif for an E3 ligase (SCF”
BackgroundSelf-citationMatsushime, H., Ewen, M. E., Strom, D. K., Kato, J.-Y., Hanks, S. K., Roussel, M. F., & Sherr, C. J. (1992) · Cell · doi:10.1016/0092-8674(92)90360-o · Cited by 897 · cited 1×
“These cells continued to synthesize D-type cyclins, which, based on earlier studies, can directly bind to and activate Cdk2 in vitro (Matsushime et al. 1992; Ewen et al. 1993).”
BackgroundSelf-citationThe B-type cyclin kinase inhibitor p40SIC1 controls the G1 to S transition in S. cerevisiae
Schwob, E. (1994) · Cell · doi:10.1016/0092-8674(94)90193-7 · Cited by 890 · cited 1×
“For example, budding yeast express a stoichiometric inhibitor of S-and M-phase Cdks, named Sic1, which accumulates as cells exit mitosis and thereby helps to institute the low Cdk activity characteristic of the G1 state (Mendenhall 1993; Schwob et al. 1994).”
BackgroundAssociation of human cyclin E with a periodic G1-S phase protein kinase
Dulic, V, Lees, E., & Reed, S. (1992) · Science · doi:10.1126/science.1329201 · Cited by 881 · cited 2×
“Unlike the cyclin D-dependent kinases, the activity of cyclin E–Cdk2 is periodic and maximal at the G1- to S-phase transition (Dulic et al. 1992; Koff et al. 1992).”
BackgroundCyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice
Ortega, S., Prieto, I., Odajima, J., Martín, A., Dubus, P., Sotillo, R., Barbero, J. L., Malumbres, M., & Barbacid, M. (2003) · Nature Genetics · doi:10.1038/ng1232 · Cited by 796 · cited 4×
“…compensatory processes achieved during early embryonic development, since acute ablation of " floxed " Cdk2 alleles by Cre-mediated recombination did not compromise their continuous proliferation in vitro, although it was not reported whether exit from quiescence was affected (Ortega et al. 2003).”
BackgroundInfluentialMammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6
Malumbres, M., Sotillo, R., Santamarı́a, D., Galán, J., Cerezo, A., Ortega, S., Dubus, P., & Barbacid, M. (2004) · Cell · doi:10.1016/j.cell.2004.08.002 · Cited by 793 · cited 8×
“Malumbres et al. 2004 CDK4 and CDK6 Progressive embryonic lethality from E14.”
BackgroundInfluentialShin, I., Yakes, F. M., Rojo, F., Shin, N.-Y., Bakin, A. V., Baselga, J., & Arteaga, C. L. (2002) · Nature Medicine · doi:10.1038/nm759 · Cited by 790 · cited 1×
“The AKT kinase controls the subcellular localization of Cip/Kip proteins as well (Liang et al. 2002; Shin et al. 2002; Viglietto et al. 2002), providing yet another avenue for cyclin E–Cdk2 regulation in response to extracellular cues.”
BackgroundCyclin-Dependent Regulation of G 1 in Mammalian Fibroblasts
Ohtsubo, M., & Roberts, J. M. (1993) · Science · doi:10.1126/science.8384376 · Cited by 756 · cited 2×
“Similarly, cyclin E overexpression can greatly accelerate G1 progression of cultured mammalian cells (Ohtsubo and Roberts 1993; Resnitzky et al. 1994), as well as those in Drosophila embryos (Knoblich et al.”
BackgroundSelf-citationHuman cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B
Pines, J., & Hunter, T. (1990) · Nature · doi:10.1038/346760a0 · Cited by 715 · cited 1×
“Another candidate for study is Cdk1, particularly because it can be activated by both cyclins A and B, which are first synthesized in late G1 and S phase, respectively (Pines and Hunter 1990).”
BackgroundViglietto, G., Motti, M. L., Bruni, P., Melillo, R. M., D'Alessio, A., Califano, D., Vinci, F., Chiappetta, G., Tsichlis, P., Bellacosa, A., et al. (2002) · Nature Medicine · doi:10.1038/nm762 · Cited by 701 · cited 1×
“The AKT kinase controls the subcellular localization of Cip/Kip proteins as well (Liang et al. 2002; Shin et al. 2002; Viglietto et al. 2002), providing yet another avenue for cyclin E–Cdk2 regulation in response to extracellular cues.”
BackgroundRane, S. G., Dubus, P., Mettus, R. V., Galbreath, E. J., Boden, G., Reddy, E. P., & Barbacid, M. (1999) · Nature Genetics · doi:10.1038/8751 · Cited by 700 · cited 3×
“Rane et al. 1999; Tsutsui et al. 1999; Zou et al. 2002; Moons et al. 2002 CDK6 Viable Thymic and splenic hypoplasia, and mild defects in hematopoiesis.”
BackgroundCyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis
Sicinski, P., Donaher, J. L., Geng, Y., Parker, S. B., Gardner, H., Park, M. Y., Robker, R. L., Richards, J. S., McGinnis, L. K., Biggers, J. D., et al. (1996) · Nature · doi:10.1038/384470a0 · Cited by 697 · cited 4×
“Impaired proliferation of peripheral B-lymphocytes Sicinski et al. 1996; Huard et al. 1999; Lam et al. 2000; Liu et al. 2000 Cyclin D3 Viable Hypoplastic thymus with loss of T-cell maturation from double-negative (CD4−, CD8−) to double-positive (CD4+, CD8+) cells due to cytokine-independent defects…”
BackgroundMethodInfluentialMice lacking cyclin D1 are small and show defects in eye and mammary gland development.
Fantl, V, Stamp, G., Andrews, A., Rosewell, I., & Dickson, C. (1995) · Genes & Development · doi:10.1101/gad.9.19.2364 · Cited by 691 · cited 4×
“This is consistent with the idea that early -catenin-driven events in the development of the alveolar lineage do not rely on cyclin D1, whereas only later differentiation steps do (Fantl et al. 1995; Sicinski et al. 1995).”
BackgroundInfluentialPhosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27Kip1
Vlach, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.17.5334 · Cited by 688
Berthet, C., Aleem, E., Coppola, V., Tessarollo, L., & Kaldis, P. (2003) · Current Biology · doi:10.1016/j.cub.2003.09.024 · Cited by 663 · cited 3×
“Moreover, cyclin Aassociated kinase activity, while present in Cdk2-null splenocyte extracts from young mice or in early-passage MEFs, was no longer detected in Cdk2-deficient adult spleen cells and in immortalized MEFs (Berthet et al. 2003).”
Cyclin E Ablation in the Mouse
Geng, Y., Yu, Q., Sicinska, E., Das, M., Schneider, J. E., Bhattacharya, S., Rideout, W. M., Bronson, R. T., Gardner, H., & Sicinski, P. (2003) · Cell · doi:10.1016/s0092-8674(03)00645-7 · Cited by 660 · cited 11×
“5 due to defects in the endoreduplication cycles that normally occur in placental trophoblast giant cells (Geng et al. 2003; Parisi et al. 2003).”
BackgroundInfluentialMouse development and cell proliferation in the absence of D-cyclins
Kozar, K., Ciemerych, M. A., Rebel, V. I., Shigematsu, H., Zagozdzon, A., Sicinska, E., Geng, Y., Yu, Q., Bhattacharya, S., Bronson, R. T., et al. (2004) · Cell · doi:10.1016/j.cell.2004.07.025 · Cited by 647 · cited 7×
“MEFs can be propagated in culture with decreased ability to enter the cell cycle from quiescence; they express aberrantly high levels of p21 C1p1 and resist transformation by oncogenic Ras + DN-p53.”
BackgroundMethodInfluentialAn essential G1 function for cyclin-like proteins in yeast
Richardson, H. E., Wittenberg, C., Cross, F., & Reed, S. I. (1989) · Cell · doi:10.1016/0092-8674(89)90768-x · Cited by 561 · cited 4×
“As early as 1989, it was recognized that two of three G1 cyclins in budding yeast could be deleted without affecting normal cell cycle progression, indicating that the cell cycle machinery either possessed considerable redundancy or was capable of robust compensation for absent components (Richardson et al. 1989).”
BackgroundInfluentialKnoblich, J. A., Sauer, K., Jones, L., Richardson, H., Saint, R., & Lehner, C. F. (1994) · Cell · doi:10.1016/0092-8674(94)90239-9 · Cited by 541 · cited 8×
“1994), as well as those in Drosophila embryos (Knoblich et al. 1994; Duronio and O’Farrell 1995).”
BackgroundInfluentialCyclin-dependent kinases regulate the antiproliferative function of Smads
Matsuura, I., Denissova, N. G., Wang, G., He, D., Long, J., & Liu, F. (2004) · Nature · doi:10.1038/nature02650 · Cited by 503 · cited 2×
“Interestingly, very recent work has indicated that cyclin D–Cdk4 complexes also phosphorylate Smad3, negatively regulating the functions of transcriptional complexes that mediate cell growth inhibition by proteins of the TGF- family (Matsuura et al. 2004).”
BackgroundClurman, B. E., Sheaff, R. J., Thress, K., Groudine, M., & Roberts, J. M. (1996) · Genes & Development · doi:10.1101/gad.10.16.1979 · Cited by 488 · cited 2×
“Phosphorylation by both GSK-3 and Cdk2 itself is required to target cyclin E for ubiquitination by the SCF E3 ligase, leading to its proteasomal destruction (Clurman et al. 1996; Won and Reed 1996; Welcker et al. 2003).”
BackgroundSelf-citationFang, F., & Newport, J. W. (1991) · Cell · doi:10.1016/0092-8674(91)90117-h · Cited by 483 · cited 1×
“Cdk2 is also essential for S phase in Drosophila (Knoblich et al. 1994; de Nooij et al. 1996; Lane et al. 1996) and in Xenopus (Fang and Newport 1991; Strausfeld et al. 1994).”
BackgroundTyers, M., Tokiwa, G., & Futcher, B. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05845.x · Cited by 475 · cited 1×
“Cln3 acts upstream of Clns 1 and 2 (Tyers et al. 1993), and elimination of all three Clns is required to induce G1 arrest (Richardson et al. 1989).”
BackgroundProliferation of cancer cells despite CDK2 inhibition
Tetsu, O., & McCormick, F. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00053-9 · Cited by 466 · cited 4×
“1993) or by Cdk4-selective drugs (Tetsu and McCormick 2003) results in G1-phase arrest and cell cycle exit.”
BackgroundInfluentialThe Developmental Biology of Brain Tumors
Wechsler-Reya, R., & Scott, M. P. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.385 · Cited by 462 · cited 2×
“(Much of the development of the cerebellum occurs in the first two postnatal weeks of a mouse's life [Wechsler-Reya and Scott 2001]; hence, the same cerebellar defects could not be evaluated in animals expressing only cyclin D1, which died before embryonic day 18.5 [E18.”
BackgroundInfluentialCDK Activity Antagonizes Whi5, an Inhibitor of G1/S Transcription in Yeast
Costanzo, M., Nishikawa, J. L., Tang, X., Millman, J. S., Schub, O., Breitkreuz, K., Dewar, D., Rupes, I., Andrews, B., & Tyers, M. (2004) · Cell · doi:10.1016/j.cell.2004.05.024 · Cited by 436 · cited 4×
“The G1 cyclins (together with their Cdk partners, not shown) promote cell cycle progression by inactivating proteins that are stoichiometric inhibitors of Cdk activity (Sic1 in yeast and p27 in mammals) as well as proteins that inhibit the program of S-phase gene expression (Whi5 in yeast and Rb family members in mamm…”
BackgroundInfluentialTargeted Disruption of CDK4 Delays Cell Cycle Entry with Enhanced p27 Kip1 Activity
Tsutsui, T., Hesabi, B., Moons, D. S., Pandolfi, P. P., Hansel, K. S., Koff, A., & Kiyokawa, H. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.7011 · Cited by 395 · cited 6×
“This was associated with increased binding of p27 Kip1 to cyclin E–Cdk2 and impaired Rb phosphorylation, a phenotype that was partially rescued in doubly null MEFs lacking both Cdk4 and p27 Kip1 (Tsutsui et al. 1999).”
BackgroundInfluentialAgami, R., & Bernards, R. (2000) · Cell · doi:10.1016/s0092-8674(00)00010-6 · Cited by 390 · cited 1×
“Cyclin D1 can also override G1-phase checkpoint arrest in response to DNA damage (Pagano et al. 1994; Agami and Bernards 2000) and the unfolded protein response (Brewer et al. 1999).”
BackgroundJiang, W. B., Kahn, S. M., Zhou, P., Zhang, Y., Cacace, A. M., Infante, A. S., Doi, S., Santella, R. M., & Weinstein, I. B. (1993) · PubMed · Cited by 386
Deregulated degradation of the cdk inhibitor p27 and malignant transformation
Bloom, J., & Pagano, M. (2003) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00098-6 · Cited by 374 · cited 2×
“et al. 1997), providing a recognition motif for an E3 ligase (SCFSkp2) that targets phosphorylated p27Kip1 for ubiquitination and its subsequent degradation by the proteasome (Elledge and Harper 1998; Bloom and Pagano 2003 ).”
BackgroundMultisite Phosphorylation by Cdk2 and GSK3 Controls Cyclin E Degradation
Welcker, M., Singer, J., Loeb, K. R., Grim, J., Bloecher, A., Gurien-West, M., Clurman, B. E., & Roberts, J. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00287-9 · Cited by 363 · cited 2×
“Phosphorylation by both GSK-3 and Cdk2 itself is required to target cyclin E for ubiquitination by the SCF E3 ligase, leading to its proteasomal destruction (Clurman et al. 1996; Won and Reed 1996; Welcker et al. 2003).”
BackgroundSelf-citationWon, K. A., & Reed, S. I. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00793.x · Cited by 360
Requirement for cyclin D3 in lymphocyte development and T cell leukemias
Sicinska, E., Aifantis, I., Le Cam, L., Swat, W., Borowski, C., Yu, Q., Ferrando, A. A., Levin, S. D., Geng, Y., von Boehmer, H., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00301-5 · Cited by 340 · cited 1×
“…Liu et al. 2000 Cyclin D3 Viable Hypoplastic thymus with loss of T-cell maturation from double-negative (CD4−, CD8−) to double-positive (CD4+, CD8+) cells due to cytokine-independent defects in pre-TCR signaling Sicinska et al. 2003 Neuropathy leading to meconium aspiration is cause of early death.”
BackgroundRescue of Cyclin D1 Deficiency by Knockin Cyclin E
Geng, Y., Whoriskey, W., Park, M. Y., Bronson, R. T., Medema, R. H., Li, T., Weinberg, R. A., & Sicinski, P. (1999) · Cell · doi:10.1016/s0092-8674(00)80788-6 · Cited by 336 · cited 2×
“In this sense, cyclin E acts downstream of cyclin D, consistent with studies in the mouse in which cyclin E coding sequences, when knocked into the cyclin D1 locus, corrected the effects of cyclin D1 deficiency (Geng et al. 1999).”
BackgroundDacapo, a Cyclin-Dependent Kinase Inhibitor, Stops Cell Proliferation during Drosophila Development
Lane, M. E., Sauer, K., Wallace, K., Jan, Y. N., Lehner, C. F., & Vaessin, H. (1996) · Cell · doi:10.1016/s0092-8674(00)81818-8 · Cited by 327 · cited 6×
“Cdk2 is also essential for S phase in Drosophila (Knoblich et al. 1994; de Nooij et al. 1996; Lane et al. 1996) and in Xenopus (Fang and Newport 1991; Strausfeld et al.”
BackgroundInfluentialRegulation of the cell cycle by the cdk2 protein kinase in cultured human fibroblasts.
Pagano, M., Pepperkok, R., Lukas, J., Baldin, V, Ansorge, W., Bartek, J., & Draetta, G. (1993) · The Journal of cell biology · doi:10.1083/jcb.121.1.101 · Cited by 322 · cited 2×
“Likewise, inhibition of Cdk2 activity by dominant-negative, catalytically inactive versions of the kinase (van den Heuvel and Harlow 1993), by microinjected antibodies to Cdk2 (Pagano et al. 1993; Tsai et al. 1993), and by induction of polypeptide inhibitors of the Cip/Kip family in many physiologic settings (Sherr an…”
Backgroundde Nooij, J. C., Letendre, M. A., & Hariharan, I. K. (1996) · Cell · doi:10.1016/s0092-8674(00)81819-x · Cited by 318 · cited 1×
“Cdk2 is also essential for S phase in Drosophila (Knoblich et al. 1994; de Nooij et al. 1996; Lane et al. 1996) and in Xenopus (Fang and Newport 1991; Strausfeld et al. 1994).”
BackgroundCyclin/Cdk-Dependent Initiation of DNA Replication in a Human Cell-Free System
Krude, T., Jackman, M., Pines, J., & Laskey, R. A. (1997) · Cell · doi:10.1016/s0092-8674(00)81863-2 · Cited by 310 · cited 2×
“In S phase, cyclin A–Cdk2 is thought to phosphorylate substrates that start DNA replication from preassembled replication initiation complexes (Krude et al. 1997; Hua and Newport 1998; Coverley et al. 2002) and to be required for coordinating the end of S phase with activation of the mitotic Cdks (Mitra and Enders 200…”
BackgroundThe cdk2 kinase is required for the G1-to-S transition in mammalian cells.
Tsai, L., Lees, E. M., Faha, B., Harlow, E. E., & Riabowol, K. T. (1993) · PubMed · Cited by 310
Fisher, D. L., & Nurse, P. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00420.x · Cited by 297 · cited 2×
“In now classic experiments, the elimination of all the then-known G1 cyclins in fission yeast still permitted their ordered progression through the cell division cycle, implying that a single enzymatic oscillator, composed of a B-type cyclin and Cdk1, may be all that is required (Fisher and Nurse 1996).”
BackgroundDistinct roles for cyclins E and A during DNA replication complex assembly and activation
Coverley, D., Laman, H., & Laskey, R. A. (2002) · Nature Cell Biology · doi:10.1038/ncb813 · Cited by 295 · cited 4×
“In S phase, cyclin A–Cdk2 is thought to phosphorylate substrates that start DNA replication from preassembled replication initiation complexes (Krude et al. 1997; Hua and Newport 1998; Coverley et al. 2002) and to be required for coordinating the end of S phase with activation of the mitotic Cdks (Mitra and Enders 200…”
BackgroundInfluentialCyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts
Pagano, M., Theodoras, A. M., Tam, S. W., & Draetta, G. F. (1994) · Genes & Development · doi:10.1101/gad.8.14.1627 · Cited by 294 · cited 2×
“Cyclin D1 can also override G1-phase checkpoint arrest in response to DNA damage (Pagano et al. 1994; Agami and Bernards 2000) and the unfolded protein response (Brewer et al.”
BackgroundDelayed early embryonic lethality following disruption of the murine cyclin A2 gene
Murphy, M., Stinnakre, M.-G., Senamaud-Beaufort, C., Winston, N. J., Sweeney, C., Kubelka, M., Carrington, M., Bréchot, C., & Sobczak-Thépot, J. (1997) · Nature Genetics · doi:10.1038/ng0197-83 · Cited by 279
Mammalian unfolded protein response inhibits cyclin D1 translation and cell-cycle progression
Brewer, J. W., Hendershot, L. M., Sherr, C. J., & Diehl, J. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8505 · Cited by 276 · cited 2×
“Cyclin D1 can also override G1-phase checkpoint arrest in response to DNA damage (Pagano et al. 1994; Agami and Bernards 2000) and the unfolded protein response (Brewer et al. 1999).”
BackgroundSelf-citationDevelopment of mice expressing a single D-type cyclin
Ciemerych, M. A., Kenney, A. M., Sicinska, E., Kalaszczynska, I., Bronson, R. T., Rowitch, D. H., Gardner, H., & Sicinski, P. (2002) · Genes & Development · doi:10.1101/gad.1023602 · Cited by 267 · cited 5×
“However, during early embryonic development, animals retaining only one D-type cyclin lose the tissue-specific expression characteristic of that gene and up-regulate the remaining cyclin in most of their tissues (Ciemerych et al. 2002).”
BackgroundMethodInfluentialThe Drosophila Cyclin D-Cdk4 complex promotes cellular growth
Datar, S. A. (2000) · The EMBO Journal · doi:10.1093/emboj/19.17.4543 · Cited by 266 · cited 3×
“Cdk4-null mice are also viable, but are small (Rane et al. 1999; Tsutsui et al. 1999), mimicking Cdk4- null flies in this regard (Datar et al. 2000).”
BackgroundCyclins E1 and E2 are required for endoreplication in placental trophoblast giant cells
Parisi, T. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg482 · Cited by 264 · cited 3×
“Notably, while neither cyclin E1 nor E2 is essential for cell cycle progression during mouse development (Geng et al. 2003; Parisi et al. 2003; see below), cyclin A2 disruption results in early embryonic lethality (Murphy et al. 1997).”
BackgroundMalek, N. P., Sundberg, H., McGrew, S., Nakayama, K., Kyriakidis, T. R., & Roberts, J. M. (2001) · Nature · doi:10.1038/35095083 · Cited by 252 · cited 4×
“Although phosphorylation of Thr 187 contributes to p27 Kip1 degradation as cells enter S phase, its turnover earlier in G1 phase is also mediated by a second pathway that does not rely on this process (Malek et al. 2001).”
BackgroundInfluentialSelf-citationCyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines.
Lukáš, J., Pagano, M., Stašková, Z., Draetta, G. F., & Bartek, J. (1994) · PubMed · Cited by 248
An Inhibitor of p34 CDC28 Protein Kinase Activity from Saccharomyces cerevisiae
Mendenhall, M. D. (1993) · Science · doi:10.1126/science.8421781 · Cited by 228 · cited 1×
“For example, budding yeast express a stoichiometric inhibitor of S-and M-phase Cdks, named Sic1, which accumulates as cells exit mitosis and thereby helps to institute the low Cdk activity characteristic of the G1 state (Mendenhall 1993; Schwob et al. 1994).”
BackgroundDuronio, R. J., & O'Farrell, P. H. (1995) · Genes & Development · doi:10.1101/gad.9.12.1456 · Cited by 228 · cited 1×
“1994), as well as those in Drosophila embryos (Knoblich et al. 1994; Duronio and O’Farrell 1995).”
BackgroundLinkage of Replication to Start by the Cdk Inhibitor Sic1
Schneider, B. L., Yang, Q.-H., & Futcher, A. B. (1996) · Science · doi:10.1126/science.272.5261.560 · Cited by 220 · cited 1×
“Hence, while yeast strains with engineered deletions of all three G1 cyclins are inviable because of an Sic1-imposed G1 arrest, this is reversed and proliferation is restored by concomitant deletion of the Sic1 gene (Schneider et al. 1996; Tyers 1996).”
BackgroundHua, X. H., & Newport, J. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.2.271 · Cited by 218 · cited 2×
“In S phase, cyclin A–Cdk2 is thought to phosphorylate substrates that start DNA replication from preassembled replication initiation complexes (Krude et al. 1997; Hua and Newport 1998; Coverley et al. 2002) and to be required for coordinating the end of S phase with activation of the mitotic Cdks (Mitra and Enders 200…”
BackgroundCerebellar histogenesis is disturbed in mice lacking cyclin D2
Huard, J. M. T., Forster, C. C., Carter, M. L., Sicinski, P., & Ross, M. E. (1999) · Development · doi:10.1242/dev.126.9.1927 · Cited by 192
Roberts, J. M. (1999) · Cell · doi:10.1016/s0092-8674(00)81007-7 · Cited by 167 · cited 5×
“…that the major differences between cyclins reflect their timing of expression, their subcellular localization, and other biochemical differences that help to mediate Cdk substrate access and selection, thereby allowing a more refined tuning of the cell cycle oscillator (Roberts 1999; Murray 2004).”
InfluentialSelf-citationDeletion of the p27 Kip1 gene restores normal development in cyclin D1-deficient mice
Geng, Y., Yu, Q., Sicinska, E., Das, M., Bronson, R. T., & Sicinski, P. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.194 · Cited by 153 · cited 4×
“…paradoxical in light of the fact that the effects of cyclin D1 deficiency in the retina and breast of living mice are rescued by p27 Kip1 loss (Geng et al. 2001; Tong and Pollard 2001), implying that cell cycle regulatory mechanisms in MEFs may not accurately reflect how these proteins…”
BackgroundInfluentialTyers, M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7772 · Cited by 145 · cited 1×
“Hence, while yeast strains with engineered deletions of all three G1 cyclins are inviable because of an Sic1-imposed G1 arrest, this is reversed and proliferation is restored by concomitant deletion of the Sic1 gene (Schneider et al. 1996; Tyers 1996).”
BackgroundZou, X., Ray, D., Aziyu, A., Christov, K., Boiko, A. D., Gudkov, A. V., & Kiyokawa, H. (2002) · Genes & Development · doi:10.1101/gad.1033002 · Cited by 142 · cited 8×
“MEFs can be propagated in culture with decreased ability to enter the cell cycle from quiescence; they express aberrantly high levels of p21 C1p1 and resist transformation by oncogenic Ras + DN-p53.”
BackgroundInfluentialHulit, J., Wang, C., Li, Z., Albanese, C., Rao, M., Di Vizio, D., Shah, S., Byers, S. W., Mahmood, R., Augenlicht, L. H., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.17.7598-7611.2004 · Cited by 142 · cited 2×
“Similarly, cyclin D1 inactivation confers resistance to breast cancers induced by oncogenic Neu or Ras transgenes targeted to the mammary gland (Yu et al. 2001) and to intestinal tumors resulting from Apc loss and constitutive -catenin signaling (Hulit et al. 2004).”
BackgroundStrausfeld, U. P., Howell, M., Rempel, R. E., Maller, J. L., Hunt, T., & Blow, J. J. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00196-2 · Cited by 138 · cited 1×
“Cdk2 is also essential for S phase in Drosophila (Knoblich et al. 1994; de Nooij et al. 1996; Lane et al. 1996) and in Xenopus (Fang and Newport 1991; Strausfeld et al. 1994).”
BackgroundCyclin D2 is essential for BCR-mediated proliferation and CD5 B cell development
Solvason, N., Wu, W. W., Parry, D., Mahony, D., Lam, E. W.-F., Glassford, J., Klaus, G. G. B., Sicinski, P., Weinberg, R., Liu, Y. J., et al. (2000) · International Immunology · doi:10.1093/intimm/12.5.631 · Cited by 135 · cited 3×
“Impaired proliferation of peripheral B-lymphocytes Sicinski et al. 1996; Huard et al. 1999; Lam et al. 2000; Liu et al. 2000 Cyclin D3 Viable Hypoplastic thymus with loss of T-cell maturation from double-negative (CD4−, CD8−) to double-positive (CD4+, CD8+) cells due to cytokine-independent defects…”
BackgroundUnmasking the S-Phase-Promoting Potential of Cyclin B1
Moore, J. D., Kirk, J. A., & Hunt, T. (2003) · Science · doi:10.1126/science.1081418 · Cited by 128 · cited 2×
“Even if low levels of Cdk activity (irrespective of the particular cyclin partner) are competent to initiate S phase, and if higher amounts are sufficient to initiate mitosis, this would require that the timing of cyclin B expression and its subcellular location be altered in the Cdk2 knockout mouse in order for cycli…”
BackgroundHigh expression of active CDK6 in the cytoplasm of CD8 memory cells favors rapid division
Veiga‐Fernandes, H., & Rocha, B. (2003) · Nature Immunology · doi:10.1038/ni1015 · Cited by 127 · cited 1×
“However, in some quiescent cells, such as memory T cells, cyclin D proteins are present in a latent form that can be activated by mitogenic signals to facilitate cell cycle re-entry (Meyyappan et al. 1998; Veiga-Fernandes and Rocha 2004).”
BackgroundMeyyappan, M., Wong, H., Hull, C., & Riabowol, K. T. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.6.3163 · Cited by 119 · cited 1×
“However, in some quiescent cells, such as memory T cells, cyclin D proteins are present in a latent form that can be activated by mitogenic signals to facilitate cell cycle re-entry (Meyyappan et al. 1998; Veiga-Fernandes and Rocha 2004).”
BackgroundThe role of protein stability in the cell cycle and cancer
Elledge, S. J., & Harper, J. W. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(98)00005-5 · Cited by 117 · cited 2×
“) that targets phosphorylated p27 Kip1 for ubiquitination and its subsequent degradation by the proteasome (Elledge and Harper 1998; Bloom and Pagano 2003).”
BackgroundLam, E. W.-F., Glassford, J., Banerji, L., Thomas, N. S. B., Sicinski, P., & Klaus, G. G. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.5.3479 · Cited by 115 · cited 3×
“Impaired proliferation of peripheral B-lymphocytes Sicinski et al. 1996; Huard et al. 1999; Lam et al. 2000; Liu et al. 2000 Cyclin D3 Viable Hypoplastic thymus with loss of T-cell maturation from double-negative (CD4−, CD8−) to double-positive (CD4+, CD8+) cells due to cytokine-independent defects…”
BackgroundCyclin A/Cdk2 complexes regulate activation of Cdk1 and Cdc25 phosphatases in human cells
Mitra, J., & Enders, G. H. (2004) · Oncogene · doi:10.1038/sj.onc.1207446 · Cited by 112 · cited 2×
“…is thought to phosphorylate substrates that start DNA replication from preassembled replication initiation complexes (Krude et al. 1997; Hua and Newport 1998; Coverley et al. 2002) and to be required for coordinating the end of S phase with activation of the mitotic Cdks (Mitra and Enders 2004).”
BackgroundSchwob, É., Böhm, T., Mendenhall, & Nasmyth, K. (1996) · Cell · Cited by 106
A premature-termination mutation in the Mus musculus cyclin-dependent kinase 3 gene
Ye, X. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041596198 · Cited by 105 · cited 1×
“However, because E-type cyclins have no known catalytic partners other than Cdk2 and Cdk3, and because Cdk3 is nonfunctional in mice (Ye et al. 2001), the differences between the cyclin E1/E2-null animals and mice lacking Cdk2 are perplexing (Roberts and Sherr 2003).”
BackgroundLack of Cyclin-Dependent Kinase 4 Inhibits c-myc Tumorigenic Activities in Epithelial Tissues
Miliani de Marval, P. L., Macias, E., Rounbehler, R., Sicinski, P., Kiyokawa, H., Johnson, D. G., Conti, C. J., & Rodriguez-Puebla, M. L. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.17.7538-7547.2004 · Cited by 101 · cited 1×
“Inactivation of Cdk4 also completely protects transgenic mice expressing c- Myc under the control of the keratin-5 promoter from developing epithelial tumors (Miliani de Marval et al. 2004).”
BackgroundGenetic Evidence for the Interactions of Cyclin D1 and p27Kip1 in Mice
Tong, W., & Pollard, J. W. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.4.1319-1328.2001 · Cited by 88 · cited 4×
“Additional experimental support for this “titration model” stems from observations that multiple phenotypic abnormalities associated with cyclin D1 deficiency in mice are rescued by deletion of p27Kip1 (Geng et al. 2001; Tong and Pollard 2001 ).”
BackgroundInfluentialCyclin F Disruption Compromises Placental Development and Affects Normal Cell Cycle Execution
Tetzlaff, M. T., Bai, C., Finegold, M. J., Wilson, J., Harper, J. W., Mahon, K. A., & Elledge, S. J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.6.2487-2498.2004 · Cited by 87
Rodríguez‐Puebla, M. L., de Marval, P. L. M., LaCava, M., Moons, D. S., Kiyokawa, H., & Conti, C. J. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64196-x · Cited by 86 · cited 1×
“Indeed, we already know that animals lacking Cdk4 are completely refractory to Ras-mediated skin carcinogenesis in vivo, whereas Cdk4 deficiency has no effect on the normal proliferation of keratinocytes in vitro (Rodriguez-Puebla et al. 2002).”
BackgroundPituitary Hypoplasia and Lactotroph Dysfunction in Mice Deficient for Cyclin-Dependent Kinase-4
Moons, D. S. (2002) · Endocrinology · doi:10.1210/en.143.8.3001 · Cited by 71 · cited 2×
“Rane et al. 1999; Tsutsui et al. 1999; Zou et al. 2002; Moons et al. 2002 CDK6 Viable Thymic and splenic hypoplasia, and mild defects in hematopoiesis.”
BackgroundPost-transcriptional regulation of cyclin D1 expression during G2 phase
Guo, Y., Stacey, D. W., & Hitomi, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205907 · Cited by 69 · cited 2×
“1998), but Rasdependent cyclin D1 synthesis and its stabilization in G2 phase allow it to reaccumulate before cells divide (Guo et al. 2002).”
BackgroundChromosome Association of Minichromosome Maintenance Proteins in Drosophila Endoreplication Cycles
Su, T. T., & O’Farrell, P. H. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.3.451 · Cited by 59 · cited 1×
“This function, previously demonstrated in Drosophila endocycles (Su and O’Farrell 1998) and in quiescent mammalian cells entering the cell cycle (Coverley et al.”
BackgroundDissecting the roles of β-catenin and cyclin D1 during mammary development and neoplasia
Rowlands, T. M., Pechenkina, I. V., Hatsell, S. J., Pestell, R. G., & Cowin, P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1534601100 · Cited by 58 · cited 2×
“Strikingly, cyclin D1 loss enhanced rather than ablated tumor formation in mice engineered to stably express a mutant form of -catenin (a target of Wnt signaling) in their mammary glands (Rowlands et al. 2003).”
BackgroundThe Yogi Book : I Really Didn't Say Everything I Said
Berra, Y. (1998) · Medical Entomology and Zoology · Cited by 56
Testing Cyclin Specificity in the Exit from Mitosis
Jacobson, M. D., Gray, S., Yuste-Rojas, M., & Cross, F. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.13.4483-4493.2000 · Cited by 48 · cited 1×
“Clb2 (a mitotic cyclin) cannot substitute for Clb5 (an S-phase cyclin) unless it is overexpressed, and Clb5 cannot trigger mitosis at all (Donaldson 2000; Jacobson et al. 2000).”
BackgroundBared essentials of CDK2 and cyclin E
Roberts, J. M., & Sherr, C. J. (2003) · Nature Genetics · doi:10.1038/ng1234 · Cited by 39 · cited 2×
“2001), the differences between the cyclin E1/E2-null animals and mice lacking Cdk2 are perplexing (Roberts and Sherr 2003).”
BackgroundSelf-citationThe yeast mitotic cyclin Clb2 cannot substitute for S phase cyclins in replication origin firing
Donaldson, A. D. (2000) · EMBO Reports · doi:10.1093/embo-reports/kvd108 · Cited by 36 · cited 1×
“Clb2 (a mitotic cyclin) cannot substitute for Clb5 (an S-phase cyclin) unless it is overexpressed, and Clb5 cannot trigger mitosis at all (Donaldson 2000; Jacobson et al. 2000).”
BackgroundCyclin D-Cdk4 Is Not a Master Regulator of Cell Multiplication in Drosophila Embryos
Meyer, C. A., Jacobs, H. W., & Lehner, C. F. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00770-4 · Cited by 32 · cited 1×
“Unlike cyclin E and Cdk2, neither cyclin D nor Cdk4 is essential for viability in Drosophila, and mutant flies lacking the latter genes develop to adulthood, although they exhibit a loss of fertility and small size (Datar et al. 2000; Meyer et al. 2002).”
BackgroundSchaefer, J. B., & Breeden, L. L. (2004) · Cell · doi:10.1016/j.cell.2004.06.008 · Cited by 31
Schwenk, F., Zevnik, B., Brüning, J. C., Rühl, M., Willuweit, A., Rode, A., Hennek, T., Kauselmann, G., Jaenisch, R., & Kühn, R. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.11.3982-3989.2003 · Cited by 31 · cited 1×
“(Although this technique guarantees that ES cells contribute only to the embryo proper, mice die of respiratory failure after birth, a process that can be bypassed by the use of hybrid ES cell strains [Schwenk et al. 2003].”
MethodMammalian Cell Cycles without Cyclin E-CDK2
Yu, Q., & Siciński, P. (2004) · Cell Cycle · doi:10.4161/cc.3.3.709 · Cited by 27 · cited 2×
“Cyclin E–Cdk2 phosphorylates a second set of substrates that are more directly involved in cell duplication; these events affect histone gene expression, centrosome duplication, replication origin licensing, and, possibly, origin firing (Yu and Sicinski 2004).”
BackgroundDeletion of the p27Kip1 gene restores normal development in cyclin D1-deficient mice
Geng, Y. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011522998 · Cited by 25
Research works printed but not linked: 1
- Resnitzky, D., Gossen, M., Bujard, H., and Reed, S.I. 1994. Ac- celeration of the G1/S phase transition by expression of cy- clins D1 and E with an inducible system. Mol. Cell. Biol. 14: 1669-1679.
Cited by
Cell cycle proteins as promising targets in cancer therapy
Otto, T., & Sicinski, P. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.138 · Cited by 1,858
Cyclin D as a therapeutic target in cancer
Musgrove, E. A., Caldon, C. E., Barraclough, J., Stone, A., & Sutherland, R. L. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3090 · Cited by 1,370
“The synthesis of individual cyclins, and consequent cyclin-dependent kinase (CDK) activation at specific cell cycle stages, coordinates the sequential completion of DNA replication and cell divisio”
BackgroundEmerging roles of E2Fs in cancer: an exit from cell cycle control
Chen, H.-Z., Tsai, S.-Y., & Leone, G. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2696 · Cited by 1,021
Cyclin-Dependent Kinase Pathways As Targets for Cancer Treatment
Shapiro, G. I. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.7689 · Cited by 1,036
“progression depicted in Figure 1.(77) For example, quiescent, serum-”
BackgroundTargeting CDK4 and CDK6: From Discovery to Therapy
Sherr, C. J., Beach, D., & Shapiro, G. I. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0894 · Cited by 936
Self-citation
Metadata
- Authors
- Sherr, C. J., & Roberts, J. M.
- Affiliations
- St. Jude Children's Research Hospital (US)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2004-11-15
- Volume
- 18
- Issue
- 22
- Pages
- 2699-2711
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2152107294
- Cited by
- 1,089
- References
- 115
- Citations by year
- 2026: 13 · 2025: 36 · 2024: 48 · 2023: 38 · 2022: 34 · 2021: 42 · 2020: 49 · 2019: 50 · 2018: 36 · 2017: 35 · 2016: 42 · 2015: 51 · 2014: 47 · 2013: 52 · 2012: 62
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- cyclin-dependent kinases, cyclins, D-type cyclins, G1 phase, cell cycle progression, CDK4, CDK6, CDK2, cyclin E, cyclin D, fetal development, mitogenic signaling
- MeSH terms
- Animals, Cell Cycle, Humans, Signal Transduction, Cyclins, Mice, Knockout, Cyclin-Dependent Kinases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.